These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 17617497)

  • 21. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial.
    Richter RW; Portenoy R; Sharma U; Lamoreaux L; Bockbrader H; Knapp LE
    J Pain; 2005 Apr; 6(4):253-60. PubMed ID: 15820913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetics of pregabalin in healthy subjects and patients with post-herpetic neuralgia or diabetic peripheral neuropathy.
    Shoji S; Suzuki M; Tomono Y; Bockbrader HN; Matsui S
    Br J Clin Pharmacol; 2011 Jul; 72(1):63-76. PubMed ID: 21306415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability of pregabalin in partial epilepsy.
    Beydoun A; Nasreddine W; Atweh S
    Expert Rev Neurother; 2008 Jul; 8(7):1013-24. PubMed ID: 18590472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pregabalin: in the treatment of postherpetic neuralgia.
    Frampton JE; Foster RH
    Drugs; 2005; 65(1):111-8; discussion 119-20. PubMed ID: 15610058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pregabalin in the treatment of refractory neuropathic pain: results of a 15-month open-label trial.
    Stacey BR; Dworkin RH; Murphy K; Sharma U; Emir B; Griesing T
    Pain Med; 2008 Nov; 9(8):1202-8. PubMed ID: 18346060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pregabalin--profile of efficacy and tolerability in neuropathic pain].
    Stump P
    Drugs Today (Barc); 2009 Oct; 45 Suppl C():19-27. PubMed ID: 20087482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study.
    Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
    Curr Med Res Opin; 2009 Jul; 25(7):1663-76. PubMed ID: 19485723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy.
    Beydoun A; Uthman BM; Kugler AR; Greiner MJ; Knapp LE; Garofalo EA;
    Neurology; 2005 Feb; 64(3):475-80. PubMed ID: 15699378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of pregabalin in patients with diabetic peripheral neuropathy or postherpetic neuralgia: Open-label, non-comparative, flexible-dose study.
    Baron R; Brunnmüller U; Brasser M; May M; Binder A
    Eur J Pain; 2008 Oct; 12(7):850-8. PubMed ID: 18242109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective.
    Tarride JE; Gordon A; Vera-Llonch M; Dukes E; Rousseau C
    Clin Ther; 2006 Nov; 28(11):1922-34. PubMed ID: 17213013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial.
    Kwan P; Brodie MJ; Kälviäinen R; Yurkewicz L; Weaver J; Knapp LE
    Lancet Neurol; 2011 Oct; 10(10):881-90. PubMed ID: 21889410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pregabalin (Lyrica) and neuropathic pain syndromes].
    Jacquy J; Lossignol D; Sternon J
    Rev Med Brux; 2006; 27(5):445-50. PubMed ID: 17144644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pregabalin for the treatment of painful neuropathy.
    Sonnett TE; Setter SM; Campbell RK
    Expert Rev Neurother; 2006 Nov; 6(11):1629-35. PubMed ID: 17144773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy.
    Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
    Curr Med Res Opin; 2009 Jul; 25(7):1677-87. PubMed ID: 19480610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Replacement of gabapentin with pregabalin in postherpetic neuralgia therapy.
    Ifuku M; Iseki M; Hidaka I; Morita Y; Komatus S; Inada E
    Pain Med; 2011 Jul; 12(7):1112-6. PubMed ID: 21692969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-response of pregabalin for diabetic peripheral neuropathy, postherpetic neuralgia, and fibromyalgia.
    Arnold LM; McCarberg BH; Clair AG; Whalen E; Thomas N; Jorga A; Pauer L; Vissing R; Park PW
    Postgrad Med; 2017 Nov; 129(8):921-933. PubMed ID: 28967801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study.
    Tölle T; Freynhagen R; Versavel M; Trostmann U; Young JP
    Eur J Pain; 2008 Feb; 12(2):203-13. PubMed ID: 17631400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pregabalin pharmacology and its relevance to clinical practice.
    Ben-Menachem E
    Epilepsia; 2004; 45 Suppl 6():13-8. PubMed ID: 15315511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery.
    Taylor CP; Angelotti T; Fauman E
    Epilepsy Res; 2007 Feb; 73(2):137-50. PubMed ID: 17126531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pregabalin: its efficacy, safety and tolerability profile in generalized anxiety.
    Owen RT
    Drugs Today (Barc); 2007 Sep; 43(9):601-10. PubMed ID: 17940637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.